Internal Medicine 1503 - Internal Medicine Alert - Feb 15, 2011

Target Audience:

This activity is intended for the internist and family practitioner.

Accreditation:

AHC Media is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation:

AHC Media designates this enduring material for a maximum of 1.75 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
 
Internal Medicine Alert has been reviewed and is acceptable for up to 1 Prescribed credit by the American Academy of Family Physicians. AAFP accreditation begins 01/01/11. Term of approval is for one year from this date. Credit may be claimed for 1 year from the date of each issue.

Faculty

Editor
Stephen Brunton, MD
Adjunct Clinical Professor
University of North Carolina, Chapel Hill

Peer Reviewer
Gerald Roberts, MD
Assistant Clinical Professor of Medicine
Albert Einstein College of Medicine
New York, NY

Associate Editors
Harold L. Karpman MD, FACC, FACP
Clinical Professor of Medicine
UCLA School of Medicine

Barbara A. Phillips, MD, MSPH
Professor of Medicine
University of Kentucky
Director
Sleep Disorders Center
Samaritan Hospital
Lexington

Matthew E. Fink, MD
Iterim Chair
Neurologist-in-Chief
Director
Division of Stroke & Critical Care Neurology
Weill Cornell Medical College
New York Presbyterian Hospital
New York, NY

William T. Elliott, MD, FACP
Chair, Formulary Committee
Northern California Kaiser Permanente
Assistant Clinical Professor of Medicine
University of California
San Francisco

James Chan, PharmD, PhD
Pharmacy Quality and Outcomes Manager
Kaiser Permanente
Oakland, CA

Louis Kuritzky, MD
Clinical Assistant Professor
University of Florida
Gainesville

Ken Grauer, MD
Professor
Assistant Director
Family Practice Residency Program
University of Florida

Subjects:

  • Is Lower BP Always Really Better?
  • Early to Bed? Maybe Not Such a Good Idea
  • Brief Reports: A Review of Current Clinical Stroke Literature
  • Pharmacology Update: Fentanyl Sublingual Tablets (Abstral®) CII
  • Clinical Briefs By Louis Kuritzky, MD
  • ECG Review: History Is Everything

Objectives:

  • describe new findings in differential diagnosis and treatment of various diseases
  • describe controversies, advantages, and disadvantages of those advances
  • describe cost-effective treatment regimens
  • describe the pros and cons of new screening procedures.

Financial Disclosure:

Internal Medicine Alert’s editor, Stephen Brunton, MD, is a consultant for Amylin, Novo Nordisk, Shionogi Pharma, Takeda, and Teva; he serves on the speakers bureau of Boehringer Ingelheim, Novo Nordisk, and Teva. Associate editors Harold L. Karpman, MD, FACC, FACP, Allan J. Wilke, MD, MA, William T. Elliott, MD, FACP, James Chan, PharmD, PhD, and peer reviewer Gerald Roberts, MD, report no financial relationship to this field of study. Associate editor Louis Kuritzky, MD is a consultant for Abbott, AstraZeneca, Boehringer Ingelheim, Daiichi, Sankyo, Forest Pharmaceuticals, Lilly, Novo Nordisk, Takeda. Associate editor Ken Grauer, MD is the sole proprietor of KG-EKG Press, and publisher of an ECG pocket brain book. Associate editor Barbara A. Phillips, MD, MSPH is a consultant for Cephalon, and serves on the speakers bureaus for Resmed and Respironics.

Copyright 2011 AHC Media. All rights reserved.